Added to YB: 2025-02-03
Pitch date: 2025-01-31
ROG.SW [neutral]
Roche Holding AG
+15.16%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
Market Cap
CHF 240.6B
Pitch Price
CHF 275.10
Price Target
N/A
Dividend
3.46%
EV/EBITDA
11.29
P/E
23.88
EV/Sales
4.21
Sector
Pharmaceuticals
Category
growth
Cognac, Cars and Animal Food - Roche Holding AG
ROG.SW (overview): 2024 solid but unspectacular. 7% sales growth, margin up to 34.4%. 2025 guidance cautious: mid-single-digit sales, high-single-digit EPS growth. CHF 1.2B loss-of-exclusivity headwind. Key pipeline readouts in 2025 could drive re-rating. Trading at premium vs peers despite weaker growth.
Read full article (1 min)